Literature DB >> 12909412

Modulation of leukocyte populations and immune responses in sheep experimentally infected with Anaplasma (formerly Ehrlichia) phagocytophilum.

S K Whist1, A K Storset, G M Johansen, H J S Larsen.   

Abstract

Anaplasma phagocytophilum infection in sheep is characterized by an immune suppression as indicated by impaired antibody response, reduced lymphocyte response and reduced oxidative burst. The effect of A. phagocytophilum infection on leucocyte populations, especially lymphocytes, was therefore investigated in six sheep experimentally infected with A. phagocytophilum, and compared with leucocyte populations from control animals.To investigate the ability of the infection to interfere with the cellular and humoral responses to specific antigens, the animals were vaccinated with commercial vaccines at the time of experimental infection, and monitored for 56 days. There were reduced percentages of gammadelta T-cells and CD4+ T-cells in peripheral blood of infected animals throughout the study period, and these cell populations showed a down-regulation of CD25 expression; while there was a relative increase in CD8+ T-cells. The reduction in CD25+ gammadelta T-cells involved a subpopulation of WC1+ gammadelta T-cells. During the first 2 weeks of the study there were reduced percentages of B-cells and leukocytes expressing MHC II and CD11b, though this decrease changed to a relative increase later in the study. The relative reductions in leucocyte populations corresponded with the observed leucopenia during the first 3 weeks post-infection, which involved lymphocyte, neutrophil and eosinophil subsets [Vet. Immunol. Immunopathol. 86 (2002) 183]. There was a reduced expression of CD11b and CD14 on granulocytes during the first 2 weeks of the study, which corresponded with the previously reported leucopenia involving neutrophils and eosinophils. Antibody responses to vaccines, lymphocyte in vitro proliferative responses to antigens and mitogens, and in vitro IFN-gamma responses to antigens were reduced up to 4 weeks after infection.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12909412     DOI: 10.1016/s0165-2427(03)00101-6

Source DB:  PubMed          Journal:  Vet Immunol Immunopathol        ISSN: 0165-2427            Impact factor:   2.046


  6 in total

1.  Reduced number of interleukin-12 secreting cells in patients with Lyme borreliosis previously exposed to Anaplasma phagocytophilum.

Authors:  S Jarefors; M Karlsson; P Forsberg; I Eliasson; J Ernerudh; C Ekerfelt
Journal:  Clin Exp Immunol       Date:  2006-02       Impact factor: 4.330

2.  Ehrlichia chaffeensis TRP32 interacts with host cell targets that influence intracellular survival.

Authors:  Tian Luo; Jere W McBride
Journal:  Infect Immun       Date:  2012-04-30       Impact factor: 3.441

Review 3.  Adaptive immunity to Anaplasma pathogens and immune dysregulation: implications for bacterial persistence.

Authors:  Wendy C Brown
Journal:  Comp Immunol Microbiol Infect Dis       Date:  2012-01-04       Impact factor: 2.268

4.  Variant-specific and diminishing immune responses towards the highly variable MSP2(P44) outer membrane protein of Anaplasma phagocytophilum during persistent infection in lambs.

Authors:  Erik G Granquist; Snorre Stuen; Liliana Crosby; Anna M Lundgren; A Rick Alleman; Anthony F Barbet
Journal:  Vet Immunol Immunopathol       Date:  2009-07-30       Impact factor: 2.046

Review 5.  Epidemiologic, Clinical and Immunological Consequences of Co-Infections during Canine Leishmaniosis.

Authors:  Erin A Beasley; Danielle Pessôa-Pereira; Breanna M Scorza; Christine A Petersen
Journal:  Animals (Basel)       Date:  2021-11-10       Impact factor: 2.752

6.  Anaplasma phagocytophilum MSP4 and HSP70 Proteins Are Involved in Interactions with Host Cells during Pathogen Infection.

Authors:  Marinela Contreras; Pilar Alberdi; Lourdes Mateos-Hernández; Isabel G Fernández de Mera; Ana L García-Pérez; Marie Vancová; Margarita Villar; Nieves Ayllón; Alejandro Cabezas-Cruz; James J Valdés; Snorre Stuen; Christian Gortazar; José de la Fuente
Journal:  Front Cell Infect Microbiol       Date:  2017-07-05       Impact factor: 5.293

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.